Assessing Illustrated Medication Labels

January 30, 2026 updated by: Wayne Sanderson

Assessing the Impact of Illustrated Medication Labels on Medication Understanding Among Migrant and Seasonal Farmworkers in South Georgia

The goal of this clinical trial is to evaluate the impact of graphic-based medication labels on medication understanding and to assess the health literacy of our farmworker population. The main questions it aims to answer are:

Primary Objective: Assess the impact of illustrated medication labels on medication understanding among migrant and seasonal farmworkers Secondary Objective: Evaluate the health literacy of the farmworker population in South Georgia

Participants will be given either medication labels with pictures or standard medication labels

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Georgia
      • Atlanta, Georgia, United States, 30322
        • Emory University
    • Kentucky
      • Lexington, Kentucky, United States, 40506
        • University of Kentucky

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults aged 18 and older
  • Receiving medication education at Emory Farm Worker Project (EFP) clinics

Exclusion Criteria:

  • Individuals unable to provide informed consent or participate in the study
  • Those not requiring medication during their visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard medication label
Behavioral: standard medication label
Standard Education Procedure: Based on best practices, including simple, standardized instructions in the participants' native language and the "teach-back" method.
Experimental: Illustrated medication label
Behavioral: Illustrated medication label
Illustrated medication labels: Labels will include visuals for medication name, time of administration, food interactions, indications, and potential side effects

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medication Understanding Questionnaire (MUQ)
Time Frame: Post intervention (10 minutes)
MUQ will assess participants' understanding of their medications after education. Scores range from 0-3 to test medication purpose, dose, and frequency
Post intervention (10 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Health Literacy Screen (BHLS)
Time Frame: Post intervention (10 minutes)
The BHLS consists of 4 questions with each item being worth 1-5 points. Total score range from 4-20 with higher score equating to greater health literacy
Post intervention (10 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wayne Sanderson

Investigators

  • Principal Investigator: Jodie Guest, PhD, Emory University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 17, 2025

Primary Completion (Actual)

May 22, 2025

Study Completion (Actual)

May 22, 2025

Study Registration Dates

First Submitted

January 23, 2026

First Submitted That Met QC Criteria

January 30, 2026

First Posted (Actual)

February 5, 2026

Study Record Updates

Last Update Posted (Actual)

February 5, 2026

Last Update Submitted That Met QC Criteria

January 30, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 105049
  • U54OH007547 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe